Celldex Therapeutics: 52-Week High Recently Eclipsed (CLDX) Financial News Network Online The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection. In the past 52 weeks, Celldex Therapeutics share prices have been bracketed by a low of ... |
